Lv4
450 积分 2023-08-04 加入
New ways of mitigating aldosterone in cardiorenal disease
1个月前
已完结
Drugs in Development to Treat IgA Nephropathy
5个月前
已完结
Targeting APRIL to slow progression of IgA nephropathy
5个月前
已完结
APRIL — Springtime for New IgA Nephropathy Therapy?
5个月前
已完结
Complement Activation and Effector Pathways in Membranous Nephropathy
8个月前
已完结
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
8个月前
已完结
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
9个月前
已完结
From inflammation to renal fibrosis: A one-way road in autoimmunity?
1年前
已完结
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management
1年前
已完结
皖公网安备34019202002308
